Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-14 5:21 pm Purchase | 13G | XERIS BIOPHARMA HLDGS INC XERS | Sessa Capital (Master) L.P. | 3,259,804 2.4% | 3,259,804 (New Position) | View |
| 2021-07-12 08:29 am Sale | 13G | XERIS PHARMACEUTICALS INC XERS | BlackRock Inc. BLK | 1,684,166 2.5% | -1,963,052 (-53.82%) | View |
| 2021-03-17 11:01 am Purchase | 13G | XERIS PHARMACEUTICALS INC XERS | Flynn James E | 12,435,751 9.88% | 6,553,398 (+111.41%) | View |
| 2021-02-16 4:39 pm Purchase | 13G | XERIS PHARMACEUTICALS INC XERS | Sessa Capital (Master) L.P. | 6,607,100 9.99% | 4,125,817 (+166.28%) | View |
| 2021-02-16 4:11 pm Sale | 13G | XERIS PHARMACEUTICALS INC XERS | Redmile Group LLC | 2,397,441 4.9% | -603,200 (-20.10%) | View |
| 2021-02-16 1:29 pm Purchase | 13G | XERIS PHARMACEUTICALS INC XERS | ArrowMark Colorado Holdings LLC | 1,981,909 3.3% | 53,601 (+2.78%) | View |
| 2021-02-12 12:31 pm Purchase | 13G | XERIS PHARMACEUTICALS INC XERS | Flynn James E | 5,882,353 4.985% | 3,299,062 (+127.71%) | View |
| 2021-02-11 08:54 am Sale | 13G | XERIS PHARMACEUTICALS INC XERS | SOROS FUND MANAGEMENT LLC | 0 0% | -2,487,581 (Position Closed) | View |
| 2021-02-01 08:30 am Purchase | 13G | XERIS PHARMACEUTICALS INC XERS | BlackRock Inc. BLK | 3,647,218 7.4% | 1,450,471 (+66.03%) | View |
| 2020-07-10 4:09 pm Purchase | 13G | XERIS PHARMACEUTICALS INC XERS | SOROS FUND MANAGEMENT LLC | 2,487,581 5.26% | 2,487,581 (New Position) | View |
| 2020-03-10 10:13 am Sale | 13G | XERIS PHARMACEUTICALS INC XERS | CITIGROUP INC C | 506,033 1.4% | -1,695,806 (-77.02%) | View |
| 2020-02-21 4:05 pm Purchase | 13G | XERIS PHARMACEUTICALS INC XERS | Sessa Capital (Master) L.P. | 2,481,283 6.9% | 2,481,283 (New Position) | View |
| 2020-02-14 4:40 pm Purchase | 13G | XERIS PHARMACEUTICALS INC XERS | ArrowMark Colorado Holdings LLC | 1,928,308 7.14% | 1,928,308 (New Position) | View |
| 2020-02-14 4:26 pm Purchase | 13G | XERIS PHARMACEUTICALS INC XERS | Redmile Group LLC | 3,000,641 11.1% | 587,999 (+24.37%) | View |
| 2020-02-13 12:49 pm Purchase | 13G | XERIS PHARMACEUTICALS INC XERS | Flynn James E | 2,583,291 9.57% | 162,650 (+6.72%) | View |
| 2020-02-07 11:24 am Purchase | 13G | XERIS PHARMACEUTICALS INC XERS | CITIGROUP INC C | 2,201,839 8.2% | 2,201,839 (New Position) | View |
| 2020-02-07 08:45 am Purchase | 13G | XERIS PHARMACEUTICALS INC XERS | BlackRock Inc. BLK | 2,196,747 8.1% | 2,196,747 (New Position) | View |
| 2020-01-10 10:25 am Sale | 13G | XERIS PHARMACEUTICALS INC XERS | FMR LLC | 0 0% | -2,280,968 (Position Closed) | View |
| 2019-11-08 4:59 pm Sale | 13G | XERIS PHARMACEUTICALS INC XERS | Flynn James E | 2,420,641 8.97% | -78,025 (-3.12%) | View |